We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+9.28%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.18B
AUM Growth
-$113M
Cap. Flow
-$283M
Cap. Flow %
-12.95%
Top 10 Hldgs %
39.24%
Holding
318
New
18
Increased
122
Reduced
118
Closed
20

Top Buys

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$10.9M
2
SRLN icon
State Street Blackstone Senior Loan ETF
SRLN
+$10.1M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$6.34M
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$3.94M
5
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$2.59M

Top Sells

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$122M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$51.5M
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46M
4
SPEM icon
State Street SPDR Portfolio Emerging Markets ETF
SPEM
+$36M
5
SPDW icon
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
+$29.2M

Sector Composition

Rank Sector Weight
1 Technology 13.94%
2 Healthcare 8.84%
3 Industrials 5.14%
4 Financials 5.11%
5 Consumer Discretionary 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITOT icon
276
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
$227K 0.01%
2,125
-92
-4% -$9.62K
SCHG icon
277
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$225K 0.01%
10,984
-1,240
-10% -$24.8K
ELV icon
278
Elevance Health
ELV
$81.5B
$222K 0.01%
+480
New +$202K
ABMD
279
DELISTED
Abiomed Inc
ABMD
$221K 0.01%
614
-60
-9% -$20.3K
RSP icon
280
Invesco S&P 500 Equal Weight ETF
RSP
$97B
$220K 0.01%
+1,351
New +$213K
VTV icon
281
Vanguard Morningstar Value ETF
VTV
$188B
$220K 0.01%
+1,498
New +$214K
ADSK icon
282
Autodesk
ADSK
$49.5B
$218K 0.01%
+773
New +$225K
HPQ icon
283
HP
HPQ
$24.9B
$207K 0.01%
+5,482
New +$179K
SPGI icon
284
S&P Global
SPGI
$121B
$207K 0.01%
+439
New +$201K
VFC icon
285
VF Corp
VFC
$5.63B
$204K 0.01%
+2,791
New +$204K
NOC icon
286
Northrop Grumman
NOC
$77.1B
$203K 0.01%
+525
New +$196K
INVA icon
287
Innoviva
INVA
$1.55B
$202K 0.01%
11,720
-271
-2% -$4.62K
OCSL icon
288
Oaktree Specialty Lending
OCSL
$1.02B
$174K 0.01%
7,785
– –
HDSN
289
Hudson Technologies
HDSN
$254M
$148K 0.01%
33,422
– –
HRTX icon
290
Heron Therapeutics
HRTX
$93.9M
$105K ﹤0.01%
11,527
-1,625
-12% -$16.6K
NAK
291
Northern Dynasty Minerals
NAK
$784M
$104K ﹤0.01%
318,950
– –
AVEO
292
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$91K ﹤0.01%
19,380
-2,260
-10% -$14K
ASX icon
293
ASE Group
ASX
$77.3B
$84K ﹤0.01%
10,781
– –
ADMA icon
294
ADMA Biologics
ADMA
$1.96B
$76K ﹤0.01%
54,186
– –
RBBN icon
295
Ribbon Communications
RBBN
$377M
$61K ﹤0.01%
10,030
– –
ITRM
296
DELISTED
Iterum Therapeutics
ITRM
$58K ﹤0.01%
9,789
-805
-8% -$6.22K
AGRX
297
DELISTED
Agile Therapeutics
AGRX
$41K ﹤0.01%
42
-8
-16% -$11.3K
RGLS
298
DELISTED
Regulus Therapeutics
RGLS
$19K ﹤0.01%
6,108
-1,059
-15% -$4.71K
ALB icon
299
Albemarle
ALB
$13.9B
– –
-976
Closed -$214K
AMD icon
300
Advanced Micro Devices
AMD
$776B
– –
-2,104
Closed -$217K
9 10 11
12
13

Similar funds

DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

Grimes & Company's Q4 2021 Portfolio in Review

As of Q4 2021, Grimes & Company held 318 positions worth $2.18B, down 4.9% from $2.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Grimes & Company withdrew a net $283M in Q4 2021, closing 20 positions and reducing 118 holdings. Its most notable exit was First Trust Preferred Securities and Income ETF, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Grimes & Company opened a new position in JPMorgan Ultra-Short Income ETF worth $2.58M.

  • Grimes & Company's largest Q4 2021 buy was JPMorgan Ultra-Short Income ETF: 51,110 shares worth $2.58M.
  • Grimes & Company added most to State Street Technology Select Sector SPDR ETF in Q4 2021, an estimated $10.9M increase.
  • Grimes & Company's biggest Q4 2021 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $51.5M.
  • Grimes & Company fully exited First Trust Preferred Securities and Income ETF in Q4 2021, selling an estimated $122M.
  • Grimes & Company's ten largest holdings make up 39% of its $2.18B portfolio in Q4 2021.
  • Grimes & Company opened 18 new positions and closed 20 in Q4 2021.
  • Grimes & Company's portfolio value fell 4.9% quarter-over-quarter to $2.18B.

Based on Grimes & Company's 13F filing for Q4 2021, filed 1 Feb 2022.